Prevalence and Main Features of Chronic Refractory Cough.
NCT ID: NCT04078542
Last Updated: 2019-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2020-01-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A careful clinical history may provide important diagnostic clues that allow therapeutic trials without the need of further investigations.\[5\] Smoking history, medication list and presence and character of sputum should be carefully detailed. Identification of the causes of productive cough is generally straightforward and strategies for intervention and treatment are well defined.\[5\] Conversely, chronic dry or poorly productive cough represents a greater diagnostic challenge. Several studies have shown that in nonsmokers with normal chest radiography who are not taking ACE-inhibitor, chronic cough is usually due to asthma, rhinosinusitis or gastro-esophageal reflux (GER).\[6\] Many dedicated algorithms have been identified to guide the diagnostic phase and to sequentially coordinate the execution of further diagnostic deepening and/or empirical treatments, based on cost-effectiveness principles.\[5,7-9\] Among these, the European Respiratory Society (ERS) recommendations\[5\] are widely applied in clinical practice and broadly parallel those released by the American College of Chest Physicians\[7\]. This notwithstanding, a proportion of cases do not reach a definite diagnosis and resolutive treatment\[7\]. This condition is termed chronic refractory cough (CRC), chronic idiopathic cough, or unexplained chronic cough.\[7,10\] It can be diagnosed when patients have no identified causes of chronic cough (unexplained or idiopathic chronic cough) or when the cough persists after investigation and treatment of cough-related conditions. Because patients with unexplained chronic cough often receive specific therapies, such as inhaled corticosteroids or proton pump inhibitors, they can also be classified as having CRC.
The real prevalence of CRC is not well-know and many cases of CRC may be actually misdiagnoses due an incomplete application of recommended work-up. In the present study we aim to estimate the prevalence of chronic cough in different care settings, together with the prevalence of CRC according to a systematic and integrated approach. The careful application of the recommendation defined by ERS guidelines will allow to detect truly refractory cases of chronic cough.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
China Chronic Cough Registry: a Multicenter, Prospective, Observational Study
NCT06862362
Prospective Study on the Evaluation, Patient Reported Outcomes and Effectiveness of Treatment for Chronic Cough
NCT04758351
An Observational Study Using Novel Questionnaire to Characterize Cough Phenotypes in Patients With Chronic Cough
NCT06376448
Characteristics of Postinfectious Cough
NCT06951321
COllaboration REsearch on Chronic Cough (COREC): a French Multicenter Database
NCT04882943
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic cough
Subject complaining cough from at least 8 weeks
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Campus Bio-Medico University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Raffaele Antonelli Incalzi
Full Professor of Internal Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raffaele Antonelli Incalzi, MD
Role: PRINCIPAL_INVESTIGATOR
Campus Bio Medico
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Campus Bio-Medico di Roma
Roma, , Italy
IRCCS Maugeri Tradate
Roma, , Italy
Policlinico Universitario Agostino Gemelli Università Cattolica del Sacro Cuore
Roma, , Italy
Policlinico Universitario Agostino Gemelli Università Cattolica del Sacro Cuore
Roma, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ComEtx
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.